IDEAS home Printed from https://ideas.repec.org/a/gam/jijerp/v18y2021i2p387-d475802.html
   My bibliography  Save this article

Prevalence of Hyperuricemia and the Use of Allopurinol in Older Poles—Results from a Population-Based PolSenior Study

Author

Listed:
  • Mateusz Winder

    (Department of Internal Medicine and Oncological Chemotherapy, Medical University of Silesia, 40-029 Katowice, Poland)

  • Aleksander J. Owczarek

    (Department of Statistics, Department of Instrumental Analysis, Faculty of Pharmaceutical Sciences in Sosnowiec, Medical University of Silesia, 41-200 Katowice, Poland)

  • Małgorzata Mossakowska

    (International Institute of Molecular and Cell Biology, 02-109 Warsaw, Poland)

  • Katarzyna Broczek

    (Department of Geriatrics, Medical University of Warsaw, 02-007 Warsaw, Poland)

  • Tomasz Grodzicki

    (Department of Internal Medicine and Gerontology, Jagiellonian University Medical College, 31-531 Krakow, Poland)

  • Łukasz Wierucki

    (Department of Preventive Medicine and Education, Medical University of Gdańsk, 80-210 Gdansk, Poland)

  • Jerzy Chudek

    (Department of Internal Medicine and Oncological Chemotherapy, Medical University of Silesia, 40-029 Katowice, Poland)

Abstract

Background: Our study analyzes the frequency and risk factors of hyperuricemia and the use of allopurinol in a representative cohort of the older Polish adult population. Methods: The analysis was a part of a cross-sectional PolSenior study on aging in Poland. The complete medication data were available in 4873 out of 4979 community dwelling respondents aged 65 and over. Serum uric acid concentrations were evaluated in 4028 participants (80.9% of the cohort). Results: Hyperuricemia was observed in 28.2% of women and 24.7% of men. Ten risk factors of hyperuricemia were selected based on multivariable LASSO logistic regression analysis. Nine factors showed significant odds ratios: eGFR < 60 mL/min/1.73 m 2 (OR = 4.10), hypertriglyceridemia (OR = 1.88), obesity (OR = 1.75), heart failure (1.70), CRP > 3.0 mg/dL (OR = 1.64), coronary artery disease (OR = 1.30), use of loop-diuretics (OR = 4.20), hydrochlorothiazide (OR = 2.96), and thiazide-like diuretics (OR = 2.81). Allopurinol was used by 2.8% of men and 1.8% of women. The therapy was considered effective in 46.7% of men and 53.3% of women. Conclusions: Hyperuricemia was present in 23.1% (95% CI: 21.8–24.4) of the older Polish population. The frequency of hyperuricemia increases with age, reaching 30.5% in men and 33.7% in women aged 90 years or more. Chronic kidney disease, obesity, heart failure, hypertriglyceridemia, and the use of diuretics were the strongest risk factors for hyperuricemia in older adults. The treatment with allopurinol was ineffective in more than half of participants.

Suggested Citation

  • Mateusz Winder & Aleksander J. Owczarek & Małgorzata Mossakowska & Katarzyna Broczek & Tomasz Grodzicki & Łukasz Wierucki & Jerzy Chudek, 2021. "Prevalence of Hyperuricemia and the Use of Allopurinol in Older Poles—Results from a Population-Based PolSenior Study," IJERPH, MDPI, vol. 18(2), pages 1-14, January.
    • Handle: RePEc:gam:jijerp:v:18:y:2021:i:2:p:387-:d:475802
    as

    Download full text from publisher

    File URL: https://www.mdpi.com/1660-4601/18/2/387/pdf
    Download Restriction: no
    File URL: https://www.mdpi.com/1660-4601/18/2/387/
    Download Restriction: no
    ---><---

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Sanja Zuzic Furlan & Doris Rusic & Josko Bozic & Mirjana Rumboldt & Zvonko Rumboldt & Marko Rada & Marion Tomicic, 2021. "How Are We Managing Patients with Hyperuricemia and Gout: A Cross Sectional Study Assessing Knowledge and Attitudes of Primary Care Physicians?," IJERPH, MDPI, vol. 18(3), pages 1-11, January.
    2. Sidsel Dan Hull & Marianne Welzel Andersen & Jessica Bengtsson & Nils Skovgaard & Marie Balslev Backe & Michael Lynge Pedersen, 2022. "Prevalence of Patients Receiving Urate-Lowering Medicine in Greenland and Denmark: A Cross-Sectional Case–Control Study," IJERPH, MDPI, vol. 19(12), pages 1-8, June.
    3. Anna Chudek & Przemysław Kotyla & Małgorzata Mossakowska & Tomasz Grodzicki & Tomasz Zdrojewski & Magdalena Olszanecka-Glinianowicz & Jerzy Chudek & Aleksander J. Owczarek, 2022. "The Prevalence of Anticitrullinated Protein Antibodies in Older Poles—Results from a Population-Based PolSenior Study," IJERPH, MDPI, vol. 19(21), pages 1-12, October.

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:gam:jijerp:v:18:y:2021:i:2:p:387-:d:475802. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: MDPI Indexing Manager (email available below). General contact details of provider: https://www.mdpi.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.